Suppr超能文献

从红曲米中分离出的红色素红斑红曲素和他汀类化合物莫纳可林L的端粒酶抑制作用

Telomerase Inhibitory Effects of Red Pigment Rubropunctatin and Statin Monacolin L Isolated from Red Yeast Rice.

作者信息

Xu Baojun, Wang Qijun, Sung Changkeun

机构信息

Food Science and Technology Program, Beijing Normal University-Hong Kong Baptist University United International College, Zhuhai 519085, China.

College of Food and Bioengineering, South China University of Technology, Guangzhou 510640, China.

出版信息

Genes (Basel). 2017 Apr 26;8(5):129. doi: 10.3390/genes8050129.

Abstract

In addition to the cholesterol-lowering activity of red yeast rice (RYR), its anticancer activities have been frequently reported. However, the mechanism of action of the anticancer activity of RYR is not yet fully understood. The objective of the current study was to elucidate anticancer compositions and anticancer mechanism of actions of RYR. The isolated compounds from RYR were subjected to anti-proliferation assay, apoptosis assay via flow cytometry, and telomerase inhibitory assay via telomeric repeat amplification protocol-PCR (TRAP-PCR) assay, and Western blotting assay in an in vitro cell culture system. The results showed that a statin, monacolin L, and a red pigment, rubropunctatin, from RYR exhibited very strong cancer cell proliferation inhibitory effects; the rubropunctatin was comparable with anticancer drug -platinum, taxol, and 10-hydroxy-camptothecin (HCPT) in their IC values. Monacolin L and rubropunctatin exerted their anticancer activity via telomerase inhibitory effects. Monacolin L and rubropunctatin presented the similar telomerase inhibitory effects as the anticancer drug -platinum, while the anticancer drug HCPT presented a weak telomerase inhibitory effect in the TRAP-PCR assay. Meanwhile, rubropunctatin and -platinum did not present strong apoptosis induction activity as the momacolin L and HCPT did. These results indicate that the RYR may exert anticancer effects through the telomerase inhibitory effect of rubropunctatin and the apoptosis-induction effect of monacolin L.

摘要

除了红曲米(RYR)的降胆固醇活性外,其抗癌活性也经常被报道。然而,RYR抗癌活性的作用机制尚未完全明确。本研究的目的是阐明RYR的抗癌成分及其抗癌作用机制。在体外细胞培养系统中,对从RYR中分离出的化合物进行抗增殖试验、通过流式细胞术进行凋亡试验、通过端粒重复扩增协议 - 聚合酶链反应(TRAP - PCR)试验进行端粒酶抑制试验以及蛋白质印迹试验。结果表明,来自RYR的一种他汀类药物莫纳可林L和一种红色色素红斑红曲素表现出非常强的癌细胞增殖抑制作用;红斑红曲素在其半数抑制浓度(IC)值方面与抗癌药物顺铂、紫杉醇和10 - 羟基喜树碱(HCPT)相当。莫纳可林L和红斑红曲素通过端粒酶抑制作用发挥其抗癌活性。在TRAP - PCR试验中,莫纳可林L和红斑红曲素表现出与抗癌药物顺铂相似的端粒酶抑制作用,而抗癌药物HCPT表现出较弱的端粒酶抑制作用。同时,红斑红曲素和顺铂不像莫纳可林L和HCPT那样具有强烈的凋亡诱导活性。这些结果表明,RYR可能通过红斑红曲素的端粒酶抑制作用和莫纳可林L的凋亡诱导作用发挥抗癌作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e78/5448003/922c8995c5c6/genes-08-00129-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验